BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Dec. 10, 2025

Dec. 10, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Adverum, Akero, Eli Lilly, Formycon, Probiogen, Novo Nordisk, Spica, Zydus.
Read More

In the clinic for Dec. 10, 2025

Dec. 10, 2025
Clinical updates, including data readouts and publications: Abcuro, Akeso, Aleta, Ascentage, Assembly, Beone, Biontech, BMS, Enterprise, Halia, Harmony, Incyte, Innovent, Johnson & Johnson, Kallyope, Kamada, Lundbeck, Lyell, Maat, March, Miltenyi, Oncoc4, ONL, Orca Bio, Realta, Structure, Targed, Terns, UCB.
Read More

Financings for Dec. 10, 2025

Dec. 10, 2025
Biopharmas raising money in public or private financings, including: Aprea, Convergen, Terns.
Read More

Appointments and advancements for Dec. 10, 2025

Dec. 10, 2025
New hires and promotions in the biopharma industry, including: Arcutis, Century, Eli Lilly, Fibrocor, Halozyme, Plur, Tessera, Tonix.
Read More

Appointments and advancements for Dec. 10, 2025

Dec. 10, 2025
New hires and promotions in the med-tech industry, including: Berlin Heals, Billiontoone, Boston Scientific, Cathvision, Fresenius, Retinalgenix, Turncare.
Read More

Financings for Dec. 10, 2025

Dec. 10, 2025
Med-tech firms raising money in public or private financings, including: Perimeter Medical Imaging.
Read More

In the clinic for Dec. 10, 2025

Dec. 10, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytovale, Mediwound, OM1, Prelude.
Read More

Other news to note for Dec. 10, 2025

Dec. 10, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Airiver Meidcal, Harmoneyes, Ifocus Health, Oncobit, Pulse Biosciences, Rapid Medical, Sibel Health, Telix, Trillumbio, Vapotherm, Xcell Biosciences.
Read More

Regulatory actions for Dec. 10, 2025

Dec. 10, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bendit Technologies, Heartbeam, Kane Biotech, Proverum, Vektor Medical.
Read More

Regulatory actions for Dec. 9, 2025

Dec. 9, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ayrmid, Incyte, Junshi, Ocular.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 1719 1720 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 18, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • GLP-1 capsule

    Maintenance, man: Lilly’s phase III weight trial hits goals

    BioWorld
    Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
  • Insilico CEO Alex Zhavoronkov and the automated lab’s humanoid that runs all preclinical tests in the Hong Kong lab.

    AI drug developer Insilico to raise $292 million in Hong Kong IPO

    BioWorld
    Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing